Next, to interrogate the possible clinical relevance of PARG in breast cancer, we evaluated the association of PARG mRNA levels with patient overall survival, first incorporating all breast cancer patients (Fig. 1d), followed by segregation into molecular subtypes. Here, PARG is linked to breast carcinoma.